Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
1887
-
Total 13F shares, excl. options
-
2.03B
-
Shares change
-
-17.8M
-
Total reported value, excl. options
-
$130B
-
Value change
-
-$1.14B
-
Put/Call ratio
-
0.74
-
Number of buys
-
842
-
Number of sells
-
-836
-
Price
-
$64.09
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2017
2,034 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2017.
Merck & Co., Inc. - Common Stock (MRK) has 1,887 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.03B shares
of 2.53B outstanding shares and own 80.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (194M shares), BlackRock Inc. (185M shares), STATE STREET CORP (121M shares), WELLINGTON MANAGEMENT GROUP LLP (107M shares), Capital World Investors (95.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (58.1M shares), Bank of New York Mellon Corp (40.5M shares), NORTHERN TRUST CORP (35.3M shares), JPMORGAN CHASE & CO (35.2M shares), and BANK OF AMERICA CORP /DE/ (35M shares).
This table shows the top 1887 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.